World Journal of Urology

, Volume 24, Issue 4, pp 371–377

Self-management in lower urinary tract symptoms: the next major therapeutic revolution

Topic Paper

Abstract

The standard treatments for men with lower urinary tract symptoms (LUTS) range from watchful waiting to medical and finally surgical intervention. However, the role of self-management interventions such as education and reassurance, lifestyle modification and behavioural changes has not been formally investigated, although they are widely advocated and utilised for LUTS. Self-management interventions are well established in other chronic diseases such as diabetes, arthritis and asthma. These interventions, if successfully organised within a structured program for LUTS, could improve patient outcomes as well as reduce the economic burden of LUTS treatment, by replacing or augmenting other treatments. Recent studies showing that long-term urodynamic and symptomatic deterioration of LUTS is minimal suggest that this is a safe and valid treatment option. This is supported by a recent pilot study of a LUTS self-management program which showed significant improvements in I-PSS and frequency–volume parameters. The results of a recently completed randomised controlled trial are awaited.

Keywords

Self-management Lower urinary tract symptoms Benign prostatic hyperplasia Watchful waiting 

References

  1. 1.
    Barry MJ, Fowler FJ Jr, Mulley AG Jr, et al. (1995) Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 33:771PubMedCrossRefGoogle Scholar
  2. 2.
    Brown CT, Emberton M (2004) Could self-management challenge pharmacotherapy as a long-term treatment for uncomplicated lower urinary tract symptoms? Curr Opin Urol 14:7PubMedCrossRefGoogle Scholar
  3. 3.
    Brown CT, O’Flynn E, van der MJ, et al. (2003) The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened? BJU Int 91:30PubMedCrossRefGoogle Scholar
  4. 4.
    Brown CT, van der MJ, Mundy AR, et al. (2003) Lifestyle and behavioural interventions for men on watchful waiting with uncomplicated lower urinary tract symptoms: a national multidisciplinary survey. BJU Int 92:53PubMedCrossRefGoogle Scholar
  5. 5.
    Brown CT, van der MJ, Mundy AR, et al. (2004) Defining the components of a self-management programme for men with uncomplicated lower urinary tract symptoms: a consensus approach. Eur Urol 46:254PubMedCrossRefGoogle Scholar
  6. 6.
    Bryant CM, Dowell CJ, Fairbrother G (2002) Caffeine reduction education to improve urinary symptoms. Br J Nurs 11:560PubMedGoogle Scholar
  7. 7.
    Burgio KL (2002) Influence of behavior modification on overactive bladder. Urology 60:72PubMedCrossRefGoogle Scholar
  8. 8.
    Caplin DL, Creer TL (2001) A self-management program for adult asthma. III. Maintenance and relapse of skills. J Asthma 38:343PubMedCrossRefGoogle Scholar
  9. 9.
    Creighton SM, Stanton SL (1990) Caffeine: does it affect your bladder? Br J Urol 66:613PubMedGoogle Scholar
  10. 10.
    Donovan JL, Kay HE, Peters TJ, et al. (1997) Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-’BPH’ Study. International Continence Society—Benign Prostatic Hyperplasia. Br J Urol 80:712PubMedGoogle Scholar
  11. 11.
    Flanigan RC, Reda DJ Wasson JH, et al. (1998) 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol 160:12PubMedCrossRefGoogle Scholar
  12. 12.
    Gass R (2002) Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJU Int 90:649PubMedCrossRefGoogle Scholar
  13. 13.
    Gibson PG, Powell H, Coughlan J, et al. (2002) Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev, CD001005Google Scholar
  14. 14.
    Griffiths DJ, McCracken PN, Harrison GM, et al. (1993) Relationship of fluid intake to voluntary micturition and urinary incontinence in geriatric patients. Neurourol Urodyn 12:1PubMedCrossRefGoogle Scholar
  15. 15.
    Health and Social Care Information Centre (2005) Prescription Cost Analysis: England 2004. Available from UK Department of Health: http://www.dh.gov.uk
  16. 16.
    Kadow C, Feneley RC, Abrams PH (1988) Prostatectomy or conservative management in the treatment of benign prostatic hypertrophy? Br J Urol 61:432PubMedCrossRefGoogle Scholar
  17. 17.
    Kirby RS (2000) The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 56:3PubMedCrossRefGoogle Scholar
  18. 18.
    Lorig K, Gonzalez VM, Laurent DD, et al. (1998) Arthritis self-management program variations: three studies. Arthritis Care Res 11:448PubMedCrossRefGoogle Scholar
  19. 19.
    Madersbacher S, Alivizatos G, Nordling J, et al. (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547PubMedCrossRefGoogle Scholar
  20. 20.
    Mattiasson A, Blaakaer J, Hoye K, et al. (2003) Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int 91:54PubMedCrossRefGoogle Scholar
  21. 21.
    Meigs JB, Mohr B, Barry MJ, et al. (2001) Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54:935PubMedCrossRefGoogle Scholar
  22. 22.
    Murray E, Davis H, Tai SS, et al. (2001) Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care. BMJ 323:493PubMedCrossRefGoogle Scholar
  23. 23.
    Newman S, Steed L, Mulligan K (2004) Self-management interventions for chronic illness. Lancet 364:1523PubMedCrossRefGoogle Scholar
  24. 24.
    Paterson J, Pinnock CB, Marshall VR (1997) Pelvic floor exercises as a treatment for post-micturition dribble. Br J Urol 79:892PubMedGoogle Scholar
  25. 25.
    Prezioso D, Catuogno C, Galassi P, et al. (2001) Life-style in patients with LUTS suggestive of BPH. Eur Urol 40(Suppl. 1):9PubMedCrossRefGoogle Scholar
  26. 26.
    Reynard J (1999) Fluid balance therapy of nocturia in women. Int Urogynecol J Pelvic Floor Dysfunct 10:43PubMedCrossRefGoogle Scholar
  27. 27.
    Thomas AW, Cannon A, Bartlett E, et al. (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int 96:1301PubMedCrossRefGoogle Scholar
  28. 28.
    Valtin H (2002) “Drink at least eight glasses of water a day.” Really? Is there scientific evidence for “8 × 8”? Am J Physiol Regul Integr Comp Physiol 283:R993PubMedGoogle Scholar
  29. 29.
    Wadden TA, Berkowitz RI, Womble LG, et al. (2005) Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 353:2111PubMedCrossRefGoogle Scholar
  30. 30.
    Wasson JH, Reda DJ, Bruskewitz RC, et al. (1995) A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 332:75PubMedCrossRefGoogle Scholar
  31. 31.
    Weingarten SR, Henning JM, Badamgarav E, et al. (2002) Interventions used in disease management programmes for patients with chronic illness—which ones work? Meta-analysis of published reports. BMJ 325:925PubMedCrossRefGoogle Scholar
  32. 32.
    Wysocki T, Harris MA, Wilkinson K, et al. (2003) Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes. Diabetes Care 26:2043PubMedCrossRefGoogle Scholar
  33. 33.
    Yang Q, Abrams P, Donovan J, et al. (1999) Transurethral resection or incision of the prostate and other therapies: a survey of treatments for benign prostatic obstruction in the UK. BJU Int 84:640PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.Clinical Effectiveness UnitRoyal College of Surgeons of EnglandLondonUK
  2. 2.Institute of Urology and NephrologyUniversity College HospitalLondonUK

Personalised recommendations